Epidemiology

Tracking changes in SARS-CoV-2 transmission with a novel outpatient sentinel surveillance system in Chicago, USA

1. Reese Richardson
2. Emile Jorgensen
3. Philip Arevalo
4. Tobias M. Holden
5. Katelyn M. Gostic
6. Massimo Pacilli
7. Isaac Ghinai
8. Shannon Lightner
9. Sarah Cobey
10. Jaline Gerardin

Reviewed by ScreenIT

Optimality of Maximal-Effort Vaccination

1. Matthew J. Penn
2. Christl A. Donnelly

Reviewed by ScreenIT

Detection Of SARS-COV-2 Variants Of Concern In Wastewater Of Leuven, Belgium

1. Mandy Bloemen
2. Leen Delang
3. Annabel Rector
4. Joren Raymenants
5. Jonathan Thibaut
6. Bram Pussig
7. Lore Fondu
8. Bert Aertgeerts
9. Marc Van Ranst
10. Chris Van Geet
11. Jef Arnout
12. Elke Wollants

Reviewed by ScreenIT

COVID-19 Vaccine effectiveness against symptomatic infection and hospitalization in Belgium, July 2021-APRIL 2022

1. Toon Braeye
2. Joris van Loenhout
3. Ruben Brondeel
4. Veerle Stouten
5. Pierre Hubin
6. Matthieu Billuart
7. Jenny Chung
8. Mathil Vandromme
9. Chloé Wyndham-Thomas
10. Koen Blot
11. Lucy Catteau

Reviewed by ScreenIT

Unrealistic Optimism in the Eye of the Storm: Positive Bias Towards the Consequences of COVID-19 During the Second and Third Waves of the Pandemic

1. Ada Maksim
2. Sławomir Śpiewak
3. Natalia Lipp
4. Natalia Dużmańska-Misiarczyk
5. Grzegorz Gustaw
6. Krzysztof Rębilas
7. Paweł Strojny

Reviewed by ScreenIT

Effectiveness of influenza vaccination against SARS-CoV-2 infection among healthcare workers in Qatar

1. Elias Tayar
2. Sami Abdeen
3. Muna Abed Alah
4. Hiam Chemaitelly
5. Iheb Bougmiza
6. Houssein H. Ayoub
7. Anvar Hassan Kaleeckal
8. Ali Nizar Latif
9. Riyazuddin Mohammad Shaik
10. Hamad Eid Al-Romaihi
11. Mohamed H. Al-Thani
12. Roberto Bertollini
13. Laith J. Abu-Raddad
14. Abdullatif Al-Khal

Reviewed by ScreenIT

Socio-economic determinants of SARS-CoV-2 infection: Results from a population-based cross-sectional serosurvey in Geneva, Switzerland

1. Hugo-Alejandro Santa-Ramírez
2. Ania Wisniak
3. Nick Pullen
4. María-Eugenia Zaballa
5. Francesco Pennacchio
6. Elsa Lorthe
7. Roxane Dumont
8. Hélène Baysson
9. Idris Guessous
10. Silvia Stringhini

Reviewed by ScreenIT

Time series modeling to estimate unrecorded burden of 12 symptomatic medical conditions among United States Medicare beneficiaries during the COVID-19 pandemic

1. Michael Melgar
2. Jessica Leung
3. Jeffrey Colombe
4. Kathleen Dooling

Reviewed by ScreenIT

A New Paper Framework to Increase Reproducibility: Example Relating to Web Pharmacovigilance During COVID-19 in Italy

1. Alessandro Rovetta
2. Lucia Castaldo

Reviewed by ScreenIT

Global variation in force-of-infection trends for human Taenia solium taeniasis/cysticercosis

1. Matthew A Dixon
2. Peter Winskill
3. Wendy E Harrison
4. Charles Whittaker
5. Veronika Schmidt
6. Astrid Carolina Flórez Sánchez
7. Zulma M Cucunuba
8. Agnes U Edia-Asuke
9. Martin Walker
10. María-Gloria Basáñez

• Curated by eLife

  Evaluation Summary:

  Basic epidemiological parameters such as the force of infection (rate at which susceptible individuals acquire the infection) remain undetermined for human infection with the neglected food-borne zoonotic cestode Taenia solium, which may cause taeniasis and cysticercosis. Dixon and colleagues address this major gap by fitting simple mathematical models to datasets that describe the prevalence of taeniasis and cysticercosis in several countries. Importantly, they found that infection acquisition rates per year vary widely (up to two orders of magnitude) across endemic settings and provide an approach for mapping the global public health impact of taeniasis and cysticercosis.

  (This preprint has been reviewed by eLife. We include the public reviews from the reviewers here; the authors also receive private feedback with suggested changes to the manuscript. Reviewer #1 agreed to share their name with the authors.)

Reviewed by eLife